Skip to content

Medical emergency? What to do

Merck's cervical cancer vaccine wins US approval

3-RXPublished June 9, 20062 min read

Key points

  • The first vaccine to prevent cervical cancer won U.S. approval on Thursday when health officials cleared a Merck & Co.
  • The vaccine blocks infection with certain types of the human papillomavirus (HPV), which causes genital warts and most cervical cancer.
  • Given in three doses over six months, Gardasil targets four HPV types believed to cause more than 70 percent of cervical cancer cases and 90 percent of genital warts.
  • The approval puts Merck ahead of GlaxoSmithKline Plc , which is developing its own HPV vaccine called Cervarix and plans to apply for U.S. clearance this year.

The first vaccine to prevent cervical cancer won U.S. approval on Thursday when health officials cleared a Merck & Co. Inc. vaccine to block a sexually transmitted infection that causes the deadly disease.

Public health experts called the Gardasil vaccine a major advance against a disease that kills about 300,000 women worldwide annually. Industry analysts said the product also should help revive the fortunes of struggling Merck with annual sales that could top $2 billion.

The vaccine blocks infection with certain types of the human papillomavirus (HPV), which causes genital warts and most cervical cancer.

"This vaccine is a significant advance in the protection of women's health in that it strikes at the infections that are the root cause of many cervical cancers," acting Food and Drug Administration Commissioner Andrew von Eschenbach said.

Given in three doses over six months, Gardasil targets four HPV types believed to cause more than 70 percent of cervical cancer cases and 90 percent of genital warts. The vaccine was approved for use in girls and women ages 9 to 26, Merck said.

The catalog price for Gardasil will be $120 per dose, the company said.

The approval puts Merck ahead of GlaxoSmithKline Plc , which is developing its own HPV vaccine called Cervarix and plans to apply for U.S. clearance this year.

Most cervical cancer deaths occur in developing countries. In the United States, widespread screening catches the disease early when it is treatable, but about 4,000 women die from it each year.

Merck is counting on Gardasil to help revive earnings growth in the face of more than 11,500 lawsuits over its recall of arthritis drug Vioxx.

Jason Fox, an analyst with H&R Block Financial Advisors, said Merck still faces several challenges, such as expected generic competition later this month to its blockbuster cholesterol treatment Zocor, but Gardasil's approval lends stability to the company's situation.

"Our bigger picture view of Merck is they really need Gardasil," Fox said. "This is their biggest pipeline opportunity in the next year."

Shares of Whitehouse Station, New Jersey-based Merck gained about 5 cents to $34 in afternoon trading on the New York Stock Exchange.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.